DePuy Synthes (Johnson & Johnson) Acquires CrossRoads Extremity Systems from HealthpointCapital

HealthpointCapital Acquires Controlling Stake in CrossRoads Extremity Systems

May 14, 2019

Medical Devices

HealthpointCapital has acquired a controlling (majority) stake in CrossRoads Extremity Systems, a Memphis-based developer and manufacturer of foot & ankle implants, procedure-specific sterile-packed instrumentation, and the EcoSMART instrument recovery service. HealthpointCapital will partner with CrossRoads' co-founders and management, providing additional equity to fund organic growth, expand the company's portfolio and market presence, and pursue bolt-on acquisitions.

HealthpointCapital-backed CrossRoads Acquires Surgical Frontiers' Implant Systems

November 25, 2019

Medical Devices

HealthpointCapital’s Fund IV portfolio company, CrossRoads Extremity Systems, completed an add-on acquisition of multiple FDA-cleared implant and soft-tissue repair technology assets from Surgical Frontiers LLC, including the KATOR, OsteoPrecise, SpeedButton and Metrics product families. The purchase, which includes issued and pending U.S. patents, strengthens CrossRoads’ extremities product portfolio and supports cross-selling and capability expansion as part of HealthpointCapital’s strategy to build a market-leading orthopedic extremities platform.

Acumed Acquires ExsoMed to Expand Upper Extremity Device Portfolio

July 6, 2022

Medical Devices

Acumed, a Colson Medical | Marmon | Berkshire Hathaway company, has acquired ExsoMed, a developer of minimally invasive intramedullary fixation devices for hand surgery. The acquisition adds ExsoMed’s threaded nails and related products to Acumed’s portfolio to broaden its minimally invasive and upper-extremity treatment offerings.

Onkos Surgical Acquires the Juvenile Tumour System (JTS) from Stryker

June 13, 2022

Medical Devices

Onkos Surgical entered into a definitive agreement to acquire the Juvenile Tumour System (JTS) extendible prosthesis from Stryker. The device enables non‑invasive implant lengthening for pediatric bone cancer and limb reconstruction cases, and the acquisition expands Onkos's musculoskeletal oncology product portfolio and clinical capabilities.

Veeva Systems Acquires Crossix Solutions for $430 Million

November 1, 2019

Data & Analytics

Veeva Systems acquired Crossix Solutions for $430 million in a transaction announced September 26, 2019 and closed November 1, 2019. Crossix — a privacy-safe patient data and analytics provider headquartered in New York City — will operate as an independent business unit within Veeva, with Crossix CEO Asaf Evenhaim continuing to lead; certain Crossix employees received long-term equity retention grants valued at about $120 million.

HealthpointCapital Acquires Majority Stake in IlluminOss Medical

May 1, 2020

Medical Devices

HealthpointCapital, a private equity firm focused on musculoskeletal healthcare, acquired a majority stake in IlluminOss Medical, a commercial-stage medical device company that makes the Photodynamic Bone Stabilization System for fracture repair. HealthpointCapital said it will partner with IlluminOss to accelerate commercialization, expand regulatory approvals, and drive growth in the orthopedic trauma and geriatric fracture markets. Transaction terms were not disclosed.